A study on the effect of aspirin on clinical symptoms, laboratory indices, and outcomes in patients with COVID-19

• Main Authors: Roham Azizi (Author), Maryam Dehghani Mobarakeh (Author), Reza Goujani (Author), Mohsen Nabi-Afjadi (Author), Soheil Mousavi Rizi (Author), Ahmadreza Maghsoudi (Author)
• Format: Book
• Published: Society of Diabetic Nephropathy Prevention, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Low-dose aspirin is one of the most widely used secondary prevention agents for cardiovascular disease and stroke. An unstable risk factor for chronic cardiovascular disease is a viral infection. Evidence suggests that the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2...